Mouse Anti-ENKUR Recombinant Antibody (CBFYE-0866) (CBMAB-E1324-FY)

Liu, J. H., Yang, H. L., Deng, S. T., Hu, Z., Chen, W. F., Yan, W. W., ... & Fang, W. Y. (2022). The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma. Acta Pharmacologica Sinica, 1-9.

Hou, R., Li, Y., Luo, X., Zhang, W., Yang, H., Zhang, Y., ... & Fang, W. (2022). ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis. International journal of biological sciences, 18(6), 2553.

Hou, R., Liu, X., Yang, H., Deng, S., Cheng, C., Liu, J., ... & Fang, W. (2022). Chemically synthesized cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Cancer Letters, 531, 57-70.

Hou, R., Liu, X., Yang, H., Chen, C., Liu, J., Li, Y., ... & Fang, W. Y. (2021). Cinobufotalin, a Small Chemical Drug, Suppresses Nasopharyngeal Carcinoma Metastasis by Inducing ENKUR to Depress β-Catenin/C-Jun/MYH9 Signal-Mediated p53 Ubiquitination.

Ma, Q., Lu, Y., Lin, J., & Gu, Y. (2019). ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K/Akt and MAPK/ERK signaling pathways. Journal of Cancer, 10(17), 3975.

Ma, Q., Lu, Y., & Gu, Y. (2019). ENKUR is involved in the regulation of cellular biology in colorectal cancer cells via PI3K/Akt signaling pathway. Technology in Cancer Research & Treatment, 18, 1533033819841433.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols